2-Bromo-3-methylbutyric acid | CAS:565-74-2

We serve 2-Bromo-3-methylbutyric acid CAS:565-74-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-3-methylbutyric acid

Chemical Name:2-Bromo-3-methylbutyric acid
CAS.NO:565-74-2
Synonyms:DL-2-Bromoisovaleric acid
2-Bromoisovalericacid
Molecular Formula:C5H9BrO2
Molecular Weight:181.02800
 
Physical and Chemical Properties:
Density:1.513;
Melting point:39-42oC;
Boiling point:124-126oC;
Flash point:107oC;
Index of Refraction:1.479;
 
Specification:
Appearance:White to beige crystalline powder or solid
Purity(GC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As an intermediate in organic synthesis



Contact us for information like 2-Bromo-3-methylbutyric acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromoisovalericacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-3-methylbutyric acid Use and application,DL-2-Bromoisovaleric acid technical grade,usp/ep/jp grade.


Related News: Is it safe to travel? Airlines have suspended flights, and thousands of foreign citizens in the Chinese city of Wuhan have been evacuated back to their home countries. Many countries including the US have advised against travel to China.Methyl 4,6-dichloropyridazine-3-carboxylate manufacturer At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.tert-Butyl bromoacetate supplier At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.2'-DEOXYGUANOSINE vendor As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.Authorities asked citizens not to leave the city unless there are special circumstances.